SPD485
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SPD485, covering 2015-07-09 to 2017-03-28. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD and Previously Participated in MTS Trials [Phase 3]